“…We abstracted data on numbers of patients, sex, nationality, diagnostic criteria, outcomes of additional tests performed to evaluate ECRS, and the P -values for comparisons of ECRS and non-ECRS. Analyzed outcomes were the percentage or absolute count of eosinophils [ 3 - 5 , 9 - 51 ], total non-specific immunoglobulin E (IgE) [ 3 , 4 , 13 , 15 , 16 , 19 , 21 - 23 , 30 , 35 , 39 - 41 , 48 , 52 - 54 ], endoscopic polyp score [ 3 , 9 , 28 - 30 , 32 , 33 , 37 , 38 , 40 , 41 , 43 , 51 , 52 , 54 - 59 ], nasal symptomatic score [ 3 , 31 , 33 , 37 , 40 , 41 , 46 , 50 - 52 , 55 - 58 , 60 ], olfactory function [ 23 , 25 - 27 , 30 , 37 , 41 ,…”